Neoventa has been a key player in improving obstetric care for decades. The product portfolio consists of fetal monitoring solutions and support services, including training and education. An understanding of fetal physiology is crucial for optimal foetal monitoring. To increase knowledge and skills Neoventa has developed a training program in CTG and ST-Analysis interpretation to guide professional health care providers. The training program is used in maternity units all over the globe.
The purpose of foetal monitoring during labour is to prevent oxygen deficiency that can lead to serious brain damage or fetal death. CTG has been used for over 50 years and is currently the most common fetal monitoring method. However, using only CTG monitoring has its limits. The fetus’ pulse can be affected by factors other than lack of oxygen. Most specialists in obstetrics agree that CTG does not give enough information and therefore needs to be complemented with other methods to avoid unnecessary risks and operative deliveries.
What difference does ST-Analysis make?
The ST Analysis, offered by Neoventa, is a direct measurement of foetal reaction to the stress of labour and is a unique method for fetal monitoring, serving as an adjunct to CTG. It helps clinicians detect foetuses at risk of oxygen deficiency during labour through automatic detection and alerts. ST Analysis always works in parallel with the information from the foetal ECG waveform, adding valuable information about the foetal state to the CTG tracing. In this way, ST Analysis provides a continuous, individual and central message from the fetal heart, minute by minute.
Wireless and mobile fetal monitoring
In 2017, the next generation STAN monitors were introduced by Neoventa, a complete, compact and portable device that enhances mobility during labour. The latest STAN monitors are wireless and make it possible to monitor the mother and baby throughout the labour process.
Safer and better obstetric care
Hospitals have successfully integrated the equipment into daily routine practice and improved perinatal outcomes which also have positive cost effects for the hospital. ST Analysis is the only adjunctive test that has been shown to reduce the rate of neonatal metabolic acidosis, foetal scalp blood sampling and operative vaginal births. This was demonstrated in a systematic review which analysed six randomized control trials. The studies included more than 26,000 women altogether. Introducing ST Analysis as a method and way of working in a delivery ward also has positive side effects such as increased staff knowledge of fetal physiology and CTG interpretation.
“ST Analysis is a great support for the obstetric staff as ‘a second pair of eyes’ providing valuable information about the fetus’s wellbeing during labour” says Ulf Järnberg, CEO of Neoventa. “The scientific evidence is clear on this point, by applying ST Analysis as an adjunct to CTG the number of babies born with oxygen deficiency, as well as the number of operative deliveries can be lowered significantly”.
Neoventa is committed to making every baby’s journey into the world as safe as possible. ST Analysis is a crucial tool for obstetric staff in achieving this mission, helping them to perform proper interventions at the right time – ensuring that more healthy babies are born and making vaginal births possible for more women.
